CLINICAL_TRIALS
trial_result
· 2010-08-31
Clinical Trial Update: ALF-ONE : ALFuzosin ONcE Daily [Phase 4]
Summary
Phase 4 trial of Alfuzosin taken once daily for benign prostatic hyperplasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED